ahlam1399
09-17-2016, 08:41 PM
**vartis says MS drug cut risk of disability advance in study
ZURICH (Reuters) - **vartis's investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough-to-treat form of the disease versus a placebo, the Swiss company said on Saturday, citing a new analysis of a late-stage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=C3SGRsSJnUo:y-SyvfRBqSo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=C3SGRsSJnUo:y-SyvfRBqSo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/C3SGRsSJnUo
ZURICH (Reuters) - **vartis's investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough-to-treat form of the disease versus a placebo, the Swiss company said on Saturday, citing a new analysis of a late-stage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=C3SGRsSJnUo:y-SyvfRBqSo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=C3SGRsSJnUo:y-SyvfRBqSo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=C3SGRsSJnUo:y-SyvfRBqSo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/C3SGRsSJnUo